Prognostic significance of epidermal growth factor receptor expression in distant metastatic melanoma from primary cutaneous melanoma
Annals of Dermatology Sep 27, 2021
Lee KH, Suh HY, Lee MW, et al. - Survival outcomes can be predicted via epidermal growth factor receptor (EGFR) immunostaining in distant metastatic melanoma. The EGFR expression in distant metastatic melanoma in male, no ulcer, or Breslow thickness ≤4.0 mm seemed to be involved in disease progression.
This retrospective study involved 55 cases of distant metastatic melanoma.
EGFR expression was determined via immunohistochemistry analysis of diagnostic tissues.
In distant metastatic melanoma, a significant correlation of positive EGFR expression with the absence of ulceration was evident.
EGFR expression was significantly related to poor survival, under the conditions of male gender and primary cutaneous melanoma without ulceration or Breslow thickness ≤4.0 mm.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries